September 29, 2020
Mega insurer UnitedHealth Group is now looking into the digital pharmacy space with reports that it has acquired DivvyDose. The acquisition, which was first reported by CNBC’s Christina Farr based on an anonymous source, is estimated to be worth approximately $300 million.
The company’s model is similar to Amazon’s PillPack. The startup is able to ship users their medications in pre-sorted packs...
August 3, 2020
A new digital health company focused on the European market, named HealthHero, officially launched this morning. This news comes just as it closed a deal to acquire German medical consultation platform Fernarzt.com.
HealthHero is London-based startup designed to allow users to tap into medical services 24/7 through video calls, online chats or phone calls. Patients can use the service to access...
September 13, 2017
Mountain View, California-based Livongo Health, the chronic condition management technology company founded by former Allscripts CEO Glen Tullman, has acquired Diabeto, a diabetes management company based in Piscataway, New Jersey in the US and Maharashtra in India. The terms of the acquisition were not disclosed.
Though it was founded in 2012, Diabeto really hit the scene in 2015 with an...
February 22, 2017
Patient engagement company Medfusion has acquired NexSched, which makes a patient-facing appointment scheduling tool. The terms of the deal were not disclosed.
“With NexSched, we are meeting the patient demand for an improved healthcare experience, and arming practices with the technology they need to be successful in a consumer-driven market,” Kimberly Labow, CEO of Medfusion, said in a...
March 14, 2016
Palo Alto-based health tech company HealthTap has quietly acquired Docphin, a startup that makes it easier for physicians to find and read medical research, for an undisclosed sum. Docphin was a member of Rock Health's second accelerator class back in 2012 as well as StartUp Health's second class of startups later that same year. The company, which was founded in 2010, never publicly announced a...
July 9, 2015
In one more take on the first half of 2015 funding, Health 2.0 Market Intelligence has funding for the half at $2.2 billion, compared to $2.9 billion at the half-year mark last year. They tracked 2014's total funding at $4.6 billion.
"Funding in 2015 hasn’t kept pace with 2014 but there’s no reason to panic," the report reads. "Early 2014 saw a handful of blockbuster deals (Proteus, Flatiron,...
July 17, 2014
Healthcare information technology companies, including mobile and digital health companies, raised more than twice as much in total venture capital funding in the second quarter of 2014 as they did in the first, according to a new report from communications and consulting firm Mercom.
"It was a quarter of several milestones," Raj Prabhu, CEO and cofounder of Mercom Capital Group, said in a...
May 21, 2014
In 2009 when Corventis first unveiled its technology, its main offering was an innovative fluid sensor, which was part of the array of sensors embedded in its peel-and-stick patch that was eventually named PiiX. One of the grave symptoms for heart failure patients is fluid collection in the heart -- a symptom that most remote monitoring companies track by simply keeping tabs on a patient's weight...
October 1, 2013
Boston-based Healthrageous, which spun out of Partners Healthcare's Center for Connected Health in 2010, has closed up shop and sold off its assets. The once promising venture was based partially on the Center's SmartBeat blood pressure management program, which the provider piloted with EMC employees a few years ago to prove its efficacy.
For a short while the company was called HopSkipConnect....
January 7, 2013
AthenaHealth, a provider of cloud-based EHR and practice management software, announced a definitive agreement to acquire Epocrates, a popular mobile medical app provider, for about $293 million in cash. Epocrates agreed to the offer, which was specifically $11.75 per share, a 22 percent premium over Epocrates closing price last Friday. Piper Jaffray & Co. and Cooley advised Epocrates on the...